Evidence map›Paper›PMID 38859773›Full record

ArticleCombinatorial chemistry & high throughput screening2025

Chen Yang, Yao Chen, Tao Tao, Ping Xu, Miaomiao Li, Bicheng Deng, Sihan Lu, Minfeng Yang, Weijie Wang, Jinghan Wang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Combinatorial chemistry & high throughput screening, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chen YangCollege of Life Science, North China University of Science and Technology, Bohai Avenue 21, Tangshan 063210, China.
Yao ChenJiangsu Province Engineering Research Center of Molecular Target Therapy and Companion Diagnostics in Oncology, Suzhou Vocational Health College, Kehua Road 28, Suzhou, China 215009.
Tao TaoDepartment of Respiratory and Critical Medicine, The Fifth People's Hospital of Suzhou, The Affiliated Infectious Diseases Hospital, Suzhou Medical College of Soochow University, Suzhou 215100, China.
Ping XuDepartment of Clinical Laboratory, The Fifth People's Hospital of Suzhou, The Affiliated Infectious Diseases Hospital, Suzhou Medical College of Soochow University, Suzhou 215100, China.
Miaomiao LiJiangsu Province Engineering Research Center of Molecular Target Therapy and Companion Diagnostics in Oncology, Suzhou Vocational Health College, Kehua Road 28, Suzhou, China 215009.
Bicheng DengCollege of Life Science, North China University of Science and Technology, Bohai Avenue 21, Tangshan 063210, China.
Sihan LuCollege of Life Science, North China University of Science and Technology, Bohai Avenue 21, Tangshan 063210, China.
Minfeng YangDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Weijie WangCollege of Life Science, North China University of Science and Technology, Bohai Avenue 21, Tangshan 063210, China.
Jinghan WangDepartment of Hepatobiliary and Pancreatic Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
Song-Bai LiuCollege of Life Science, North China University of Science and Technology, Bohai Avenue 21, Tangshan 063210, China.

Funding

Gusu Key Medical Talent Program of Suzhou, China GSWS2020093Key Technology Program of Suzhou People's Livelihood Technology Projects SKY2021029LingYan Programs of the Suzhou Vocational Health College szwzy202210, szwzy202011, szwzytd202201Qing-Lan Project of Jiangsu Province in China 2021, 2022Youth Scientific Research Project of Suzhou Health Commission, China KJXW2019045
6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC) has high morbidity and mortality worldwide. Excision repair cross-complement 3 (

methodsThe HCC cohort from the TCGA database included 50 normal samples and 374 tumor samples to compare the differences in

resultsThe expression of 11

conclusionThis study revealed a novel genetic signature that is significantly associated with TME cell infiltration and prognosis in HCC patients. It demonstrated that the combined action of multiple key genes associated with

Indexed as

Carcinoma, HepatocellularDNA-Binding ProteinsImmunotherapyLiver NeoplasmsHumansPrognosisTumor MicroenvironmentDNA-Binding ProteinsERCC3gene markersHCCimmunotherapy.TME

Identifiers

PMID38859773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.